William H. Westra

45.4k total citations · 13 hit papers
224 papers, 29.2k citations indexed

About

William H. Westra is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, William H. Westra has authored 224 papers receiving a total of 29.2k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Otorhinolaryngology, 99 papers in Surgery and 65 papers in Oncology. Recurrent topics in William H. Westra's work include Head and Neck Cancer Studies (113 papers), Head and Neck Surgical Oncology (38 papers) and Salivary Gland Tumors Diagnosis and Treatment (35 papers). William H. Westra is often cited by papers focused on Head and Neck Cancer Studies (113 papers), Head and Neck Surgical Oncology (38 papers) and Salivary Gland Tumors Diagnosis and Treatment (35 papers). William H. Westra collaborates with scholars based in United States, Italy and Spain. William H. Westra's co-authors include Maura L. Gillison, Wayne M. Koch, Gypsyamber DʼSouza, David Sidransky, Joseph A. Califano, Carole Fakhry, Shahnaz Begum, Arlene A. Forastiere, Raphael P. Viscidi and Christine H. Chung and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

William H. Westra

219 papers receiving 28.6k citations

Hit Papers

Human Papillomavirus and ... 1996 2026 2006 2016 2010 2008 2007 2010 2008 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
    2010 4.8k citations William H. Westra, Christine H. Chung et al. profile →
  2. Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
    2008 2.1k citations Carole Fakhry, William H. Westra et al. profile →
  3. Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
    2007 1.9k citations Gypsyamber DʼSouza, Carole Fakhry et al. profile →
  4. HPV-associated head and neck cancer: a virus-related cancer epidemic
    2010 1.4k citations Shanthi Marur, Gypsyamber DʼSouza et al. profile →
  5. Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
    2008 1.1k citations Maura L. Gillison, Gypsyamber DʼSouza et al. profile →
  6. Genetic progression model for head and neck cancer: implications for field cancerization.
    1996 1.1k citations Joseph A. Califano, William H. Westra et al. PubMed profile →
  7. BRAF Mutation in Papillary Thyroid Carcinoma
    2003 748 citations Mingzhao Xing, Elizabeth Mambo et al. profile →
  8. TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck
    2007 591 citations Joseph A. Califano, William H. Westra et al. profile →
  9. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists
    2017 390 citations Justin A. Bishop, James W. Rocco et al. profile →
  10. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experience
    2010 361 citations William H. Westra et al. Cancer profile →
  11. Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer
    2012 359 citations Maura L. Gillison, Weihong Xiao et al. Journal of Clinical Oncology profile →
  12. Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
    2014 330 citations William H. Westra, Christine H. Chung et al. Journal of Clinical Oncology profile →
  13. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
    2017 317 citations Shanthi Marur, Shuli Li et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William H. Westra United States 73 16.4k 10.9k 9.8k 8.1k 4.8k 224 29.2k
Adel K. El‐Naggar United States 99 5.4k 0.3× 11.9k 1.1× 16.8k 1.7× 12.0k 1.5× 5.7k 1.2× 679 36.4k
Wayne M. Koch United States 72 8.8k 0.5× 6.0k 0.6× 7.5k 0.8× 7.4k 0.9× 2.8k 0.6× 259 20.9k
Christine H. Chung United States 52 7.2k 0.4× 4.5k 0.4× 5.6k 0.6× 4.7k 0.6× 3.6k 0.8× 255 15.6k
Helmuth Goepfert United States 70 7.5k 0.5× 7.8k 0.7× 6.9k 0.7× 2.6k 0.3× 4.0k 0.8× 239 17.5k
Nancy Y. Lee United States 65 9.0k 0.6× 7.4k 0.7× 6.1k 0.6× 1.9k 0.2× 5.6k 1.2× 382 18.7k
Ezra E.W. Cohen United States 67 4.7k 0.3× 3.2k 0.3× 8.5k 0.9× 4.7k 0.6× 5.6k 1.2× 421 16.9k
Erich M. Sturgis United States 56 4.9k 0.3× 3.2k 0.3× 4.0k 0.4× 3.1k 0.4× 2.5k 0.5× 305 11.1k
Gary L. Clayman United States 67 3.1k 0.2× 3.4k 0.3× 5.7k 0.6× 5.0k 0.6× 1.6k 0.3× 232 13.8k
Carol R. Bradford United States 72 7.2k 0.4× 6.0k 0.6× 6.5k 0.7× 3.2k 0.4× 3.7k 0.8× 353 16.8k
Ian Ganly United States 64 3.5k 0.2× 6.1k 0.6× 5.3k 0.5× 3.4k 0.4× 2.0k 0.4× 330 15.4k

Countries citing papers authored by William H. Westra

Since Specialization
Citations

This map shows the geographic impact of William H. Westra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Westra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Westra more than expected).

Fields of papers citing papers by William H. Westra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Westra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Westra. The network helps show where William H. Westra may publish in the future.

Co-authorship network of co-authors of William H. Westra

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Westra. A scholar is included among the top collaborators of William H. Westra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Westra. William H. Westra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
DʼSouza, Gypsyamber, Lisa M. Rooper, Tanya Troy, et al.. (2022). Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time. Cancer. 128(9). 1767–1774. 17 indexed citations
3.
Guerrero‐Preston, Rafael, Fahcina Lawson, Maartje Noordhuis, et al.. (2019). JAK3 Variant, Immune Signatures, DNA Methylation, and Social Determinants Linked to Survival Racial Disparities in Head and Neck Cancer Patients. Cancer Prevention Research. 12(4). 255–270. 16 indexed citations
4.
Marur, Shanthi, Shuli Li, Anthony J. Cmelak, et al.. (2017). E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology. 35(5). 490–497. 317 indexed citations breakdown →
5.
Mattox, Austin K., Jina Lee, William H. Westra, et al.. (2017). PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs. Cancer Research. 77(22). 6365–6374. 76 indexed citations
6.
Fan, Caleb J., Linda X. Yin, David X. Li, et al.. (2017). Evaluation of proposed staging systems for human papillomavirus‐related oropharyngeal squamous cell carcinoma. Cancer. 123(10). 1768–1777. 46 indexed citations
7.
Virk, Renu K., Pei Hui, Avīnash Prasad, et al.. (2013). Tall Cell Variant of Papillary Thyroid Microcarcinoma: Clinicopathologic Features with BRAF V600E Mutational Analysis. Thyroid. 23(12). 1525–1531. 36 indexed citations
8.
Bishop, Justin A., Gaosong Wu, Ralph P. Tufano, & William H. Westra. (2012). Histological Patterns of Locoregional Recurrence in Hürthle Cell Carcinoma of the Thyroid Gland. Thyroid. 22(7). 690–694. 36 indexed citations
9.
Carvalho, André Lopes, Rui Henrique, Cármen Jerónimo, et al.. (2011). Detection of Promoter Hypermethylation in Salivary Rinses as a Biomarker for Head and Neck Squamous Cell Carcinoma Surveillance. Clinical Cancer Research. 17(14). 4782–4789. 70 indexed citations
10.
Nichols, Anthony C., Dianne M. Finkelstein, William C. Faquin, et al.. (2010). Bcl2 and Human Papilloma Virus 16 as Predictors of Outcome following Concurrent Chemoradiation for Advanced Oropharyngeal Cancer. Clinical Cancer Research. 16(7). 2138–2146. 48 indexed citations
11.
Ostrow, Kimberly Laskie, Hannah Lui Park, Mohammad Obaidul Hoque, et al.. (2009). Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer. Clinical Cancer Research. 15(4). 1184–1191. 59 indexed citations
12.
Agrawal, Yuri, Wayne M. Koch, Weihong Xiao, et al.. (2008). Oral Human Papillomavirus Infection Before and After Treatment for Human Papillomavirus 16–Positive and Human Papillomavirus 16–Negative Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 14(21). 7143–7150. 57 indexed citations
13.
Prasad, Nijaguna B., Helina Somervell, Ralph P. Tufano, et al.. (2008). Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors. Clinical Cancer Research. 14(11). 3327–3337. 66 indexed citations
14.
Upadhyay, Sunil, Chunyan Liu, Mohammad Obaidul Hoque, et al.. (2006). LKB1/STK11 Suppresses Cyclooxygenase-2 Induction and Cellular Invasion through PEA3 in Lung Cancer. Cancer Research. 66(16). 7870–7879. 37 indexed citations
15.
Park, Hannah Lui, Keishi Yamashita, Myoung Sook Kim, et al.. (2006). DCC promoter hypermethylation in esophageal squamous cell carcinoma. Cancer Research. 66. 8–8. 8 indexed citations
16.
Wu, Guojun, Motonobu Osada, Zhongmin Guo, et al.. (2005). ΔNp63α Up-Regulates the Hsp70 Gene in Human Cancer. Cancer Research. 65(3). 758–766. 88 indexed citations
17.
Hoque, Mohammad Obaidul, Eli Rosenbaum, William H. Westra, et al.. (2005). Quantitative Assessment of Promoter Methylation Profiles in Thyroid Neoplasms. The Journal of Clinical Endocrinology & Metabolism. 90(7). 4011–4018. 104 indexed citations
18.
Hoque, Mohammad Obaidul, et al.. (2004). Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal Cancer. Cancer Research. 64(15). 5511–5517. 184 indexed citations
19.
Parwani, Anil V., et al.. (2003). Solitary fibrous tumor of the thyroid: Cytopathologic findings and differential diagnosis. Diagnostic Cytopathology. 28(4). 213–216. 31 indexed citations
20.
Sánchez‐Céspedes, Montse, Paola Parrella, Manel Esteller, et al.. (2002). Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.. PubMed. 62(13). 3659–62. 495 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adel K. El‐Naggar Breakdown of academic impact, for papers by Wayne M. Koch Breakdown of academic impact, for papers by Christine H. Chung Breakdown of academic impact, for papers by Helmuth Goepfert Breakdown of academic impact, for papers by Nancy Y. Lee Breakdown of academic impact, for papers by Ezra E.W. Cohen Breakdown of academic impact, for papers by Erich M. Sturgis Breakdown of academic impact, for papers by Gary L. Clayman Breakdown of academic impact, for papers by Carol R. Bradford Breakdown of academic impact, for papers by Ian Ganly
Rankless by CCL
2026